Melanoma Group

Research Groups

Restricted acces

Structure

Chair

caroline-robert
Caroline Robert
Institut Gustave Roussy
Villejuif, France

Secretary

Alexander van Akkooi
The Netherlands Cancer Institute – Antoni Van Leeuwenhoekziekenhuis
Amsterdam, The Netherlands

Treasurer

G.-Ghanem
G. Ghanem
Institut Jules Bordet
Brussels, Belgium

Chair elect: Dirk Schadendorf, Universitaetsklinikum – Essen, Essen (DE)

Past chair: Alessandro Testori, Istituto Europeo Di Oncologia, Milano (IT)

The Melanoma Group (MG) currently has seven committees engaged in the management of cutaneous and ocular melanoma, development of new treatment strategies, and conducting epidemiological, genetic, and pathological research in melanoma. A Translational Research Committee serves to foster transversal interaction between the Pathology, Translational Research, and Epidemiology Committees.

Chair Adjuvant Therapy Committee: A.M.M. Eggermont, Paris (FR)
Chair Epidemiology Committee: S. Gandini (IT)
Chair Ocular Melanoma Committee: S. Leyvraz, Lausanne (CH)
Chair Pathology: M. Cook, Guildford (GB)
Chair Stage IV Melanoma Committee: P. Lorigan, Manchester (GB)
Chair Surgery Committee: A. Testori, Milan (IT)
Chair Translational Research Committee: D. Schadendorf, Essen (DE); L. van Kempen, Montreal (CA)
Chair Early Staging Committee: S. Puig, Barcelona (ES)
Young Oncologists / Scientists: A. Van Akkooi, Rotterdam (NL); H. Franks, Nottingham (GB)

Find us

Avenue Emmanuel Mounier, 83/11
Brussels 1200
Belgium

Contact us

Follow us

Funding